PTPRD and non-small cell lung carcinoma: The median OS difference between PTPRD mutation and wild type was not significant in the NSCLC (16.6 vs 13.2 months, HR=0.92, p=0.670, Fig. 3e), ns-NSCLC (17.3 vs 15.2 months, HR=0.90, p=0.662, Fig. 3f) or squamous subgroup (8.90 vs 8.48 months, HR=1.29, p=0.619, Additional file 2: Fig. S1h).